CHAMPIONS ONCOLOGY, INC.
For the period ended Aug 27, 2026. Filed Aug 28, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 27, 2026 · Filed Aug 28, 2026
Contents
Equity Compensation Plan Information
The following table provides information, as of April 30, 2026, with respect to all compensation arrangements maintained by the Company, including individual compensation arrangements, under which Shares are authorized for issuance. The weighted-average exercise price does not include restricted stock which is not applicable for the Company.
| Plan Category · Number of Securities to beissued upon exercise ofoutstanding options andrights · Weighted-average exerciseprice of outstandingoptions and rights · Number of securitiesremaining available forfuture issuance underequity compensation plans | ||||
|---|---|---|---|---|
| Equity compensation plans approved by stockholders (2021 Equity Incentive Plan) | 1,908,284 | $6.81 | 91,716 | |
| Equity compensation plans approved by stockholders (2010 Equity Incentive Plan) (1) | 731,536 | $3.31 | — | |
| Total | 2,639,820 | 91,716 | ||
(1) No additional grants can be made under the 2010 Equity Incentive Plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.